logo
Select company
Select metric
$ -57.41MConsolidated Income
VS
Market
18
Sector
35
Industry
17
History
3
$ 0.38Close
$ 0.28 - $ 2.82 52-Week Range
Ticker Information

Ticker

HBIO

Company Name

HARVARD BIOSCIENCE INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

HARVARD BIOSCIENCE INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HBIO - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -57.41M
3/31/2025$ -58.05M
12/31/2024$ -12.4M
9/30/2024$ -14.24M
6/30/2024$ -10.68M
3/31/2024$ -8.73M
12/31/2023$ -3.42M
9/30/2023$ -3.26M
6/30/2023$ -5.43M
3/31/2023$ -2.01M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HARVARD BIOSCIENCE INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -6.64M.
  • Over the past 5 years, HARVARD BIOSCIENCE INC's average Cons. Inc. has been $ -11.28M.
  • The median Cons. Inc. for HARVARD BIOSCIENCE INC during this period was $ -6.57M
  • HARVARD BIOSCIENCE INC reached its highest Cons. Inc. over the past 5 years at $ -288K.
  • The lowest Cons. Inc. recorded by HARVARD BIOSCIENCE INC in the same timeframe $ -58.05M

HARVARD BIOSCIENCE INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
RVP : RETRACTABLE TECHNOLOGIES INC $ -8.74MNXGL : NEXGEL INC $ -2.9MADAP : ADAPTIMMUNE THERAPEUTICS PLC $ -169.76MNSYS : NORTECH SYSTEMS INC $ -3.22MBNGO : BIONANO GENOMICS INC $ -74.33MAYTU : AYTU BIOPHARMA INC $ -13.56MIRIX : IRIDEX CORP $ -5.45MCOSM : COSMOS HEALTH INC $ -15.37MNEPH : NEPHROS INC $ 1.33MEKSO : EKSO BIONICS HOLDINGS INC $ -11.09M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

HBIO - Consolidated Income, Last 5 years

$ -58.05M

Minimum

Mar 31, 2025

$ -288K

Maximum

Dec 31, 2021

$ -11.28M

Average

$ -6.57M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M